CTRI/2023/10/059166尚未招募2 期
Efficacy of extended regimen of letrozole in infertile women with polycystic ovarian syndrome: a randomized controlled trial
AIIMS NEW DELHI0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Any patient from 21-38 years attending gynaecology OPD with features of PCOS as per modified Rotterdam criteria i.e. with 2/3 features: Oligo/anovulation, clinical and/or biochemical evidence of hyperandrogenism
- •Normal husband semen parameters as per sixth edition WHO semen analysis 2021 criteria.
- •Patient with at least one patent fallopian tube confirmed by hysterosalpingography or laparoscopy.
- •Patient with controlled thyroid disorders.
- •Patient with normal prolactin levels.
- •Patient with no ovarian surgery.
- •Patient who are not on any hormonal contraception or insulin sensitizers in last 3 months.
排除标准
- •Patients less than 21 years and more than 38 years.
- •Patient with history of endometriosis.
- •Patient with diminished ovarian reserve (AMH <1.5 ng/ml, AFC <7, FSH >10 IU/ml).
- •Patient with uncontrolled thyroid disorder.
- •Patient with hyperprolactinemia.
- •Patient with non-classical congenital adrenal hyperplasia.
研究者
相似试验
已完成
2 期
Evaluation of efficacy of Letrozole on the duration and severity of Ovarian hyperstimulation syndromeIRCT20141008019464N2Kerman University of Medical Sciences40
尚未招募
Unknown
Investigating the effect of letrozole in the treatment of ectopic pregnancyEctopic pregnancyIRCT20220902055855N1Tehran University of Medical Sciences75
进行中（未招募）
不适用
A Phase II study evaluating intermittent letrozole as adjuvant endocrine therapy for postmenopausal women with hormone-receptor positive, early stage breast cancer - NDhormone receptor positive breast cancerMedDRA version: 9.1Level: LLTClassification code 10057654Term: Breast cancer femaleEUCTR2007-002059-18-ITISTITUTO EUROPEO DI ONCOLOGIA
招募中
3 期
The effect of Letrozole on pregnancy rate in women with polycystic ovary syndromeIRCT20081007001306N12Rasht University of Medical Sciences124
进行中（未招募）
不适用
Clinical study for postmenopausal patients with early breast cancer treated with letrozole for 5 years and withdrawal of 3 months plus transdermal estrogen therapy.MedDRA version: 14.1Level: PTClassification code 10057654Term: Breast cancer femaleSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Breast cancerEUCTR2012-001978-28-ITISTITUTO EUROPEO DI ONCOLOGIA